Cerebrovascular Events During TAVR Cerebrovascular events occur in nearly all transcatheter aortic valve replacements (i.e.TAVR). These are associated with cognitive decline, 2- to 4-fold risk of future stroke, more than 3-fold risk of mortality, and more than 2-fold risk of dementia. Clinical cerebrovascular event rates as high as 9.1% have been reported following TAVR.
Come and meet Protembis at EuroPCR 2018
Paris, 22-25 May 2018
The ProtEmbo Cerebral Protection System
Facts To Know About ProtEmbo • Low-profile access via left radial artery (6Fr guiding sheath) • Simple, quick and reliable deployment • Complete coverage of all 3 aortic side branches • Deflection of microparticles as tiny as 60 microns • Suitable for a wide variety of aortic arch anatomies • Heparin coating for optimal biocompatibility • Best access route: no interference with TAVR catheter or accessories
Protembis Achieves ISO 13485:2016 Quality Management System Certification
ProtEmbo Deflects Embolic Material Away from the Brain During TAVR ProtEmbo is the best-in-class system providing a simple, quick, reliable solution to reduce the risk of cerebrovascular events during transcatheter aortic valve replacement (TAVR).
Jan 9, 2018
CAUTION: The ProtEmbo® Cerebral Protection System is approved for investigational use in Europe.